It is well established that the earlier cancer is detected, the better the likelihood of a positive treatment outcome. Now chemical analysers traditionally used to detect explosives are being investigated as a way of detecting the chemical signatures associated with lung cancer. These 'cancer breathalyzers' are currently being tested in 17 British hospitals with the aim of having non-invasive testing in clinics from 2017.